States target drug firms to reduce prices

Nations are addressing concerns over rising medication costs in the US by implementing laws to regulate pharmacy benefit managers (PBMs), especially CVS and other major companies that handle prescription coverage. Several states have passed legislation to limit PBM fees, increase transparency, and require fair reimbursements to independent pharmacies. CVS and other PBMs are fighting these restrictions through lawsuits and advertising campaigns, amid debates over their influence on drug prices and access, particularly in small towns. Congress has also introduced federal regulations to curb PBM practices.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل